視覺中國:實控人樑世平減持7.12萬股
格隆匯2月10日丨視覺中國(000681.SZ)公佈,公司於近日收悉公司控股股東暨實際控制人之一樑世平的股份減持情況。
持公司股份47.12萬股(佔公司總股本比例0.07%)的控股股東、實際控制人之一樑世平計劃於2020年2月6日至2020年2月7日以集中競價方式減持公司股份7.12萬股(佔公司總股本比例0.01%),目前已實施完畢。
樑世平與吳春紅、廖道訓、吳玉瑞、柴繼軍5名一致行動人為公司控股股東、實際控制人,本次減持前合計持有公司股份3.22億股,佔公司總股本的46.03%,其中樑世平持有本公司股份47.12萬股,佔公司總股本比例0.07%,全部為無限售條件流通股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.